Mural Oncology Correlations
| MURA Stock | 3.44 0.20 5.49% |
The current 90-days correlation between Mural Oncology plc and Puma Biotechnology is 0.02 (i.e., Significant diversification). The correlation of Mural Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Mural Oncology Correlation With Market
Modest diversification
The correlation between Mural Oncology plc and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mural Oncology plc and DJI in the same portfolio, assuming nothing else is changed.
Mural |
Moving together with Mural Stock
| 0.65 | DYAI | Dyadic International | PairCorr |
| 0.83 | ESPR | Esperion Therapeutics | PairCorr |
| 0.64 | BMY | Bristol Myers Squibb | PairCorr |
| 0.64 | DNA | Ginkgo Bioworks Holdings Sell-off Trend | PairCorr |
| 0.62 | GILD | Gilead Sciences | PairCorr |
| 0.75 | ABCL | Abcellera Biologics | PairCorr |
Moving against Mural Stock
| 0.7 | VALN | Valneva SE ADR | PairCorr |
| 0.68 | ERNA | Eterna Therapeutics | PairCorr |
| 0.49 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.46 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.46 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.4 | SLS | Sellas Life Sciences | PairCorr |
| 0.4 | GNFT | Genfit | PairCorr |
| 0.33 | LLY | Eli Lilly | PairCorr |
| 0.62 | AMGN | Amgen Inc | PairCorr |
| 0.57 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.52 | MRVI | Maravai Lifesciences | PairCorr |
| 0.41 | AKAN | Akanda Corp | PairCorr |
| 0.4 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
| 0.39 | ABBV | AbbVie Inc | PairCorr |
| 0.36 | MBIO | Mustang Bio | PairCorr |
| 0.33 | INKT | Mink Therapeutics | PairCorr |
| 0.6 | TTOO | T2 Biosystms | PairCorr |
| 0.57 | TFFP | Tff Pharmaceuticals | PairCorr |
| 0.52 | APGE | Apogee Therapeutics, | PairCorr |
| 0.48 | AVDL | Avadel Pharmaceuticals | PairCorr |
| 0.47 | BCDA | Biocardia | PairCorr |
| 0.44 | ARDX | Ardelyx | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Mural Stock performing well and Mural Oncology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mural Oncology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PBYI | 2.86 | 0.23 | 0.05 | 0.22 | 4.41 | 5.17 | 33.65 | |||
| IOVA | 3.17 | (0.49) | 0.00 | (0.17) | 0.00 | 7.18 | 22.30 | |||
| SNDX | 2.53 | (0.34) | 0.00 | (0.57) | 0.00 | 4.02 | 34.00 | |||
| PTGX | 1.95 | (0.27) | 0.00 | (0.12) | 0.00 | 3.42 | 16.19 |
Mural Oncology Corporate Executives
Elected by the shareholders, the Mural Oncology's board of directors comprises two types of representatives: Mural Oncology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mural. The board's role is to monitor Mural Oncology's management team and ensure that shareholders' interests are well served. Mural Oncology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mural Oncology's outside directors are responsible for providing unbiased perspectives on the board's policies.